OR7E15P

Across TCGA pan-cancer cohorts, OR7E15P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated OR7E15P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher OR7E15P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E15P expression acts as an unfavorable survival marker, although some lineages such as TGCT and KICH show a favorable association.

UVM, PAAD, and KIRC are the cancer types where OR7E15P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.267	0.655	.002	78	view →
PAAD	OS	Tertile	II,III,IV	0.353	0.573	.021	45	view →
KIRC	DFS	Tertile	III,IV	0.205	0.508	.008	42	view →
HNSC	DFS	Tertile	II,III,IV	0.216	0.574	.004	39	view →
BRCA	OS	Tertile	II,III,IV	0.937	0.961	.011	24	view →
READ	OS	Tertile	All	0.729	0.926	.006	21	view →
LIHC	DFS	Tertile	All	0.100	0.526	.038	18	view →
PRAD	OS	Tertile	All	0.978	0.998	.001	12	view →
COAD	OS	Tertile	IV	0.140	0.657	.035	9	view →
THYM	DFS	Quartile	II,III,IV	0.476	0.872	.011	6	view →
STAD	OS	Tertile	IV	0.278	0.555	.032	6	view →
LUAD	DFS	Tertile	All	0.125	0.376	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

OR7E15P–UVM (OS)

Open the UVM breakdown →